Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,086 | 439 | 99.9% |
| Education | $8.35 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $842.18 | 80 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $581.10 | 37 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $568.33 | 33 | $0 (2020) |
| Amgen Inc. | $511.73 | 35 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $424.84 | 30 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $345.76 | 20 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $343.52 | 20 | $0 (2020) |
| Lilly USA, LLC | $304.21 | 23 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $275.31 | 46 | $0 (2020) |
| ABBVIE INC. | $255.81 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $76.96 | 4 | Exact Sciences Corporation ($56.69) |
| 2023 | $49.83 | 3 | Exact Sciences Corporation ($34.33) |
| 2022 | $77.28 | 4 | ABBVIE INC. ($48.83) |
| 2021 | $254.46 | 16 | AbbVie Inc. ($191.48) |
| 2020 | $755.28 | 48 | PFIZER INC. ($204.86) |
| 2019 | $2,165 | 168 | PFIZER INC. ($325.07) |
| 2018 | $2,244 | 178 | AstraZeneca Pharmaceuticals LP ($263.62) |
| 2017 | $472.46 | 19 | Janssen Scientific Affairs, LLC ($197.85) |
All Payment Transactions
440 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/19/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: Oncology | ||||||
| 03/04/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: Oncology | ||||||
| 01/23/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Oncology | ||||||
| 07/27/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Oncology | ||||||
| 02/03/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Oncology | ||||||
| 07/06/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: VACCINES | ||||||
| 03/11/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: NEUROSCIENCE | ||||||
| 01/22/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: NEUROSCIENCE | ||||||
| 01/21/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/16/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/13/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: NEUROSCIENCE | ||||||
| 07/16/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: NEUROSCIENCE | ||||||
| 06/11/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROSCIENCE | ||||||
| 06/04/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 04/19/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Bone Health | ||||||
| 04/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: NEUROSCIENCE | ||||||
| 04/01/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $4.61 | General |
| Category: NEUROSCIENCE | ||||||
| 03/12/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: NEUROSCIENCE | ||||||
| 03/08/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $11.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/05/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2021 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 695 | 1,035 | $201,680 | $64,877 |
| 2022 | 9 | 662 | 979 | $203,819 | $65,487 |
| 2021 | 12 | 767 | 1,042 | $133,169 | $62,127 |
| 2020 | 13 | 1,109 | 1,466 | $154,019 | $66,734 |
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 243 | 509 | $108,926 | $30,129 | 27.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 158 | 158 | $48,664 | $20,742 | 42.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 92 | 122 | $36,722 | $10,727 | 29.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 47 | 47 | $2,679 | $1,474 | 55.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 48 | 91 | $2,821 | $866.32 | 30.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $1,425 | $784.25 | 55.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 12 | 13 | $442.00 | $152.88 | 34.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 45 | 45 | $0.45 | $0.45 | 100.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $0.25 | $0.25 | 100.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 252 | 498 | $105,052 | $31,349 | 29.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 122 | 160 | $47,544 | $15,043 | 31.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 86 | 86 | $26,040 | $11,607 | 44.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $19,221 | $4,863 | 25.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 49 | 49 | $2,793 | $1,501 | 53.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 49 | 82 | $2,542 | $785.04 | 30.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 11 | 11 | $627.00 | $339.19 | 54.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 31 | 31 | $0.31 | $0.31 | 100.0% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 13 | 13 | $0.13 | $0.13 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 250 | 486 | $68,064 | $30,319 | 44.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 100 | 100 | $18,088 | $13,794 | 76.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 125 | 149 | $33,737 | $13,479 | 40.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 59 | 59 | $2,006 | $1,153 | 57.5% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 22 | 22 | $1,980 | $894.14 | 45.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 45 | 45 | $2,538 | $797.75 | 31.4% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 44 | 58 | $3,436 | $563.18 | 16.4% |
About Dr. Richard Leach, DO
Dr. Richard Leach, DO is a Internal Medicine healthcare provider based in East Greenwich, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2005. The National Provider Identifier (NPI) number assigned to this provider is 1407852155.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Leach, DO has received a total of $6,095 in payments from pharmaceutical and medical device companies, with $76.96 received in 2024. These payments were reported across 440 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,086).
As a Medicare-enrolled provider, Leach has provided services to 3,233 Medicare beneficiaries, totaling 4,522 services with total Medicare billing of $259,224. Data is available for 4 years (2020–2023), covering 43 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location East Greenwich, RI
- Active Since 06/27/2005
- Last Updated 02/17/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1407852155
Products in Payments
- CHANTIX (Drug) $505.21
- ELIQUIS (Drug) $372.44
- FARXIGA (Drug) $367.37
- XARELTO (Drug) $325.65
- Aimovig (Biological) $315.17
- INVOKANA (Drug) $297.04
- UBRELVY (Drug) $249.88
- STIOLTO RESPIMAT (Drug) $233.43
- JANUVIA (Drug) $203.16
- TRELEGY ELLIPTA (Drug) $196.00
- TOUJEO (Drug) $170.59
- EVENITY (Biological) $143.49
- EMGALITY (Drug) $128.34
- LINZESS (Drug) $128.28
- SYMBICORT (Drug) $126.77
- TRADJENTA (Drug) $119.94
- SPIRIVA RESPIMAT (Drug) $110.42
- JARDIANCE (Drug) $93.68
- Trulance (Drug) $91.94
- Cologuard Collection Kit (Device) $91.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in East Greenwich
Dr. David Fried, Md, MD
Internal Medicine — Payments: $248,518
Dr. Todd Viccione, Md, MD
Internal Medicine — Payments: $25,434
Dr. Jonathan Martin, M.d, M.D
Internal Medicine — Payments: $13,170
Dr. Shahid Khan, Md, MD
Internal Medicine — Payments: $4,742
Leah Marano
Internal Medicine — Payments: $576.35
Silvia Pena, Md, MD
Internal Medicine — Payments: $535.25